Erasca (ERAS) Other Non-Current Assets (2020 - 2026)
Erasca (ERAS) reported Other Non-Current Assets of $1.4 million for Q1 2026, down 44.7% on a YoY basis from $2.6 million in Q1 2025, and up 254.41% quarter-over-quarter from $408000.0 in Q4 2025.
Erasca (ERAS) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Erasca has reported Other Non-Current Assets for 7 years, with the latest figure at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 44.7% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 44.7% YoY), and the FY2025 full-year result was $408000.0, changed 0.0% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $1.4 million, up from $408000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $4.4 million in Q3 2023, with the low at $408000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $1.3 million across 5 years, with a median of $408000.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets surged 975.49% — and 2024, when it plunged 90.69%.
- Erasca's Other Non-Current Assets stood at $408000.0 in 2022, then soared by 974.26% to $4.4 million in 2023, then sank by 90.69% to $408000.0 in 2024, then changed by 0.0% to $408000.0 in 2025, then jumped by 254.41% to $1.4 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.4 million (Q1 2026), $408000.0 (Q4 2025), and $408000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Erasca | 4.16 Bn | 3.92 Bn | - | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 408,000.00 |
| Sep 30, 2025 | 408,000.00 |
| Jun 30, 2025 | 408,000.00 |
| Mar 31, 2025 | 2.62 Mn |
| Dec 31, 2024 | 408,000.00 |
| Sep 30, 2024 | 3.88 Mn |
| Jun 30, 2024 | 408,000.00 |
| Mar 31, 2024 | 408,000.00 |
| Dec 31, 2023 | 4.38 Mn |
| Sep 30, 2023 | 4.39 Mn |
| Jun 30, 2023 | 408,000.00 |
| Mar 31, 2023 | 408,000.00 |
| Dec 31, 2022 | 408,000.00 |
| Sep 30, 2022 | 408,000.00 |
| Jun 30, 2022 | 408,000.00 |
| Mar 31, 2022 | 408,000.00 |
| Dec 31, 2021 | 2.91 Mn |
| Sep 30, 2021 | 408,000.00 |
| Jun 30, 2021 | 408,000.00 |